Biodefense Blind Spot: Why Washington Confuses Pandemics with Bioweapons

Why It Matters

As AI tools lower the expertise barrier for creating harmful biological agents, the risk of non‑state actors engineering pathogens that bypass existing defenses rises sharply. Recognizing and addressing this blind spot is crucial for national security, ensuring that policy, funding, and institutional structures keep pace with the rapidly evolving biotech threat landscape.